Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Open-market buy See Footnote 1 bought 17,410 shares at $2.33 ($40,546)
  2. 4 Open-market buy See Footnote 1 bought 104,713 shares at an average $2.32 ($242,729)
  3. 4 Open-market buy See Footnote 1 bought 103,984 shares at an average $2.31 ($239,778)
  4. 4/A Open-market buy See Footnote 1 bought 122,342 shares at $2.26 ($276,309)
  5. 3/A Insider 3/A
  6. 4 Open-market buy See Footnote 1 bought 122,342 shares at $2.26 ($276,309)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy S.V.P., General Counsel bought 50,000 shares at $2.26 ($113,210)
  13. 4 Open-market buy Director bought 10,000 shares at $3.19 ($31,947)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 10,000 shares at $3.23 ($32,345)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 23 · 459 filings